Abstract 4139639: Clinical Outcomes after Ventricular Tachycardia Ablation With or Without Induction

Introduction: Substrate mapping may offer a safer alternative to VT mapping by avoiding prolonged episodes of VT during catheter ablation. However, VT induction to gauge procedural efficacy is still routinely attempted following substrate ablation, thereby exposing patients to potentially unnecessary hemodynamic risk. Objective: To assess the feasibility and efficacy of VT ablation without any attempted VT induction. Methods: Patients with ICDs who underwent VT ablation between August 2020 and May 2023 were assessed retrospectively. Ablation and induction strategies were at the operators’ discretion. Patients with or without attempted VT induction were compared with respect to 6-month VT burden reduction using univariable linear regression; and the 1-year incidence of recurrent VT, heart transplant or death using multivariable Cox regression. Results: Eighty-nine consecutive patients (median age 68 years, 89% male, 51% infarct-related cardiomyopathy, mean LVEF 38%) were followed for a median of 16 months after VT ablation. VT induction was attempted in 63% of patients. The median (IQR) reduction in VT burden was similar in the induction and non-induction groups (96% [0%, 100%] vs. 100% [93%, 100%], p = 0.20). There was no difference between induction and non-induction groups in the 1-year incidence of recurrent VT, heart transplant or death (62% vs. 42%, HR 1.26, 95% CI 0.61-2.62, p=0.54) after adjusting for cardiomyopathy type, VT storm, pre-ablation cardiac CT/MRI, baseline creatinine, pre-ablation VT burden and the presence of NYHA Class III-IV heart failure symptoms. Conclusion: In a single-center study of 89 consecutive VT ablations, a non-induction strategy was equally effective to an induction strategy in reducing 6-month VT burden and 1-year risk of VT recurrence, transplant or death. Our findings suggest that VT induction, recognized as a risk factor for hemodynamic compromise, may be avoided in some patients without sacrificing procedural efficacy.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4139639
Primary Topic
Cardiac Arrhythmias and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4139639: Clinical Outcomes after Ventricular Tachycardia Ablation With or Without Induction

André d’Ávila, Timothy Maher, Andrew H. Locke, Jonathan W. Waks et al.
Circulation
Cardiac Arrhythmias and Treatments
article

Abstract 4139639: Clinical Outcomes after Ventricular Tachycardia Ablation With or Without Induction

André d’Ávila, Timothy Maher, Andrew H. Locke, Jonathan W. Waks, Benjamin Freedman, Shu Yang
article en

Abstract

Introduction: Substrate mapping may offer a safer alternative to VT mapping by avoiding prolonged episodes of VT during catheter ablation. However, VT induction to gauge procedural efficacy is still routinely attempted following substrate ablation, thereby exposing patients to potentially unnecessary hemodynamic risk. Objective: To assess the feasibility and efficacy of VT ablation without any attempted VT induction. Methods: Patients with ICDs who underwent VT ablation between August 2020 and May 2023 were assessed retrospectively. Ablation and induction strategies were at the operators’ discretion. Patients with or without attempted VT induction were compared with respect to 6-month VT burden reduction using univariable linear regression; and the 1-year incidence of recurrent VT, heart transplant or death using multivariable Cox regression. Results: Eighty-nine consecutive patients (median age 68 years, 89% male, 51% infarct-related cardiomyopathy, mean LVEF 38%) were followed for a median of 16 months after VT ablation. VT induction was attempted in 63% of patients. The median (IQR) reduction in VT burden was similar in the induction and non-induction groups (96% [0%, 100%] vs. 100% [93%, 100%], p = 0.20). There was no difference between induction and non-induction groups in the 1-year incidence of recurrent VT, heart transplant or death (62% vs. 42%, HR 1.26, 95% CI 0.61-2.62, p=0.54) after adjusting for cardiomyopathy type, VT storm, pre-ablation cardiac CT/MRI, baseline creatinine, pre-ablation VT burden and the presence of NYHA Class III-IV heart failure symptoms. Conclusion: In a single-center study of 89 consecutive VT ablations, a non-induction strategy was equally effective to an induction strategy in reducing 6-month VT burden and 1-year risk of VT recurrence, transplant or death. Our findings suggest that VT induction, recognized as a risk factor for hemodynamic compromise, may be avoided in some patients without sacrificing procedural efficacy.

CirculationVol. 150(Suppl_1)
Tufts Medical Center (US), Beth Israel Deaconess Medical Center (US), Beth Israel Deaconess Hospital (US)
Good health and well-being
Openalex Percentile: Top 62%
Cardiac Arrhythmias and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.